These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 28035360)
1. Hepatic inflammatory cytokine production can be regulated by modulating sphingomyelinase and ceramide synthase 6. Kim MH; Ahn HK; Lee EJ; Kim SJ; Kim YR; Park JW; Park WJ Int J Mol Med; 2017 Feb; 39(2):453-462. PubMed ID: 28035360 [TBL] [Abstract][Full Text] [Related]
2. Acid sphingomyelinase-derived ceramide is not required for inflammatory cytokine signalling in murine macrophages. Manthey CL; Schuchman EH Cytokine; 1998 Sep; 10(9):654-61. PubMed ID: 9770326 [TBL] [Abstract][Full Text] [Related]
3. The effects of restraint stress on ceramide metabolism disorders in the rat liver: the role of CerS6 in hepatocyte injury. Liu Y; Sun Z; Sun Q; Wang L; Wang C; Li Y; Ma C; Shi W; Zhang G; Dong Y; Zhang X; Cong B Lipids Health Dis; 2024 Mar; 23(1):68. PubMed ID: 38431645 [TBL] [Abstract][Full Text] [Related]
4. A novel role for ceramide synthase 6 in mouse and human alcoholic steatosis. Williams B; Correnti J; Oranu A; Lin A; Scott V; Annoh M; Beck J; Furth E; Mitchell V; Senkal CE; Obeid L; Carr RM FASEB J; 2018 Jan; 32(1):130-142. PubMed ID: 28864659 [TBL] [Abstract][Full Text] [Related]
5. Acid sphingomyelinase inhibition suppresses lipopolysaccharide-mediated release of inflammatory cytokines from macrophages and protects against disease pathology in dextran sulphate sodium-induced colitis in mice. Sakata A; Ochiai T; Shimeno H; Hikishima S; Yokomatsu T; Shibuya S; Toda A; Eyanagi R; Soeda S Immunology; 2007 Sep; 122(1):54-64. PubMed ID: 17451462 [TBL] [Abstract][Full Text] [Related]
6. Expression of Ceramide Synthase 6 Transcriptionally Activates Acid Ceramidase in a c-Jun N-terminal Kinase (JNK)-dependent Manner. Tirodkar TS; Lu P; Bai A; Scheffel MJ; Gencer S; Garrett-Mayer E; Bielawska A; Ogretmen B; Voelkel-Johnson C J Biol Chem; 2015 May; 290(21):13157-67. PubMed ID: 25839235 [TBL] [Abstract][Full Text] [Related]
7. C16‑ceramide and sphingosine 1‑phosphate/S1PR2 have opposite effects on cell growth through mTOR signaling pathway regulation. Kim MH; Park JW; Lee EJ; Kim S; Shin SH; Ahn JH; Jung Y; Park I; Park WJ Oncol Rep; 2018 Nov; 40(5):2977-2987. PubMed ID: 30226616 [TBL] [Abstract][Full Text] [Related]
8. Induction of proinflammatory cytokines by long-chain saturated fatty acids in human macrophages. Håversen L; Danielsson KN; Fogelstrand L; Wiklund O Atherosclerosis; 2009 Feb; 202(2):382-93. PubMed ID: 18599066 [TBL] [Abstract][Full Text] [Related]
9. Hepatic triglyceride accumulation via endoplasmic reticulum stress-induced SREBP-1 activation is regulated by ceramide synthases. Kim YR; Lee EJ; Shin KO; Kim MH; Pewzner-Jung Y; Lee YM; Park JW; Futerman AH; Park WJ Exp Mol Med; 2019 Nov; 51(11):1-16. PubMed ID: 31676768 [TBL] [Abstract][Full Text] [Related]
10. Synovial fibroblasts and the sphingomyelinase pathway: sphingomyelin turnover and ceramide generation are not signaling mechanisms for the actions of tumor necrosis factor-alpha. Gerritsen ME; Shen CP; Perry CA Am J Pathol; 1998 Feb; 152(2):505-12. PubMed ID: 9466577 [TBL] [Abstract][Full Text] [Related]
11. The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach. Raichur S; Brunner B; Bielohuby M; Hansen G; Pfenninger A; Wang B; Bruning JC; Larsen PJ; Tennagels N Mol Metab; 2019 Mar; 21():36-50. PubMed ID: 30655217 [TBL] [Abstract][Full Text] [Related]
12. Involvement of de novo ceramide synthesis in pro-inflammatory adipokine secretion and adipocyte-macrophage interaction. Hamada Y; Nagasaki H; Fujiya A; Seino Y; Shang QL; Suzuki T; Hashimoto H; Oiso Y J Nutr Biochem; 2014 Dec; 25(12):1309-16. PubMed ID: 25283329 [TBL] [Abstract][Full Text] [Related]
13. CerS2 haploinsufficiency inhibits β-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance. Raichur S; Wang ST; Chan PW; Li Y; Ching J; Chaurasia B; Dogra S; Öhman MK; Takeda K; Sugii S; Pewzner-Jung Y; Futerman AH; Summers SA Cell Metab; 2014 Oct; 20(4):687-95. PubMed ID: 25295789 [TBL] [Abstract][Full Text] [Related]
14. By activating Fas/ceramide synthase 6/p38 kinase in lipid rafts, stichoposide D inhibits growth of leukemia xenografts. Yun SH; Park ES; Shin SW; Ju MH; Han JY; Jeong JS; Kim SH; Stonik VA; Kwak JY; Park JI Oncotarget; 2015 Sep; 6(29):27596-612. PubMed ID: 26318294 [TBL] [Abstract][Full Text] [Related]
16. Ceramide signalling and the immune response. Ballou LR; Laulederkind SJ; Rosloniec EF; Raghow R Biochim Biophys Acta; 1996 Jun; 1301(3):273-87. PubMed ID: 8664339 [TBL] [Abstract][Full Text] [Related]
17. Regulated secretion of acid sphingomyelinase: implications for selectivity of ceramide formation. Jenkins RW; Canals D; Idkowiak-Baldys J; Simbari F; Roddy P; Perry DM; Kitatani K; Luberto C; Hannun YA J Biol Chem; 2010 Nov; 285(46):35706-18. PubMed ID: 20807762 [TBL] [Abstract][Full Text] [Related]
18. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells. Endale M; Park SC; Kim S; Kim SH; Yang Y; Cho JY; Rhee MH Immunobiology; 2013 Dec; 218(12):1452-67. PubMed ID: 23735482 [TBL] [Abstract][Full Text] [Related]
19. Role of nuclear factor-kappaB activation in cytokine- and sphingomyelinase-stimulated inducible nitric oxide synthase gene expression in vascular smooth muscle cells. Katsuyama K; Shichiri M; Marumo F; Hirata Y Endocrinology; 1998 Nov; 139(11):4506-12. PubMed ID: 9794459 [TBL] [Abstract][Full Text] [Related]
20. Ceramide plays a prominent role in MDA-7/IL-24-induced cancer-specific apoptosis. Sauane M; Su ZZ; Dash R; Liu X; Norris JS; Sarkar D; Lee SG; Allegood JC; Dent P; Spiegel S; Fisher PB J Cell Physiol; 2010 Mar; 222(3):546-55. PubMed ID: 19937735 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]